Tag

UF startup

CROs dMed and Clinipace Merge To Accelerate Customer Success

dMed Global, a full-service Clinical Contract Research Organization (CRO) based in Shanghai, China, and UF startup Clinipace Incorporated, a full-service clinical CRO with headquarters in North Carolina, USA, announced that the two companies will merge.

New OxThera/Oxabact US Patent Granted

UF startup OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces that a new US patent has been granted for its product candidate Oxabact and a method for the treatment or prevention of an oxalate-related disorder, such as hyperoxaluria.

Plasma Oxalate and Kidney Function Are Correlated in Patients With Primary Hyperoxaluria With Maintained Kidney Function – Data From Three Placebo-Controlled Studies Published

UF startup OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces the publication of an article in Pediatric Nephrology, on the significant correlation between plasma oxalate and kidney function in three controlled clinical trials with PH patients.

UF Startup Shadow Health Is Going Big and Staying Home

In early December, local UF startup Shadow Health, which develops virtual simulations for nursing and healthcare education, became part of Elsevier, a global leader in information and analytics, that is part of RELX, an even larger global provider of information-based analytics. The acquisition will hasten Shadow Health’s ability to reach its biggest goals.